Quantum Genesis AI Corp. (OTC: QGAI) issued a press release on May 19, 2026, to clarify the relationship between its research activities and those of Quantumzyme LLP, a separate entity based in Bengaluru, India. The clarification addresses prior press releases from November 5, 2025, and February 12, 2026, which referenced scientific publications in the enzyme engineering and biocatalysis field. Those publications had identified Quantumzyme LLP and reflected the affiliations of researchers at the time of submission. The Company emphasizes that Quantumzyme LLP is not a subsidiary or affiliate of Quantum Genesis AI.
The statement underscores that intellectual property and technology rights were transferred to Quantum Genesis AI pursuant to an Asset Purchase Agreement dated February 21, 2023, and a subsequent confirmatory assignment filed on April 29, 2026. The agreement transferred certain intellectual property, know-how, methodologies, processes, and research materials from the Company’s Chief Executive Officer, Naveen Kulkarni, to Quantum Genesis AI. The Company believes that research activities conducted by Mr. Kulkarni, whether directly or through Quantumzyme LLP, that are based on or derived from the transferred technology platform fall within the scope of the rights transferred to the Company.
This clarification is significant for investors and stakeholders as it delineates the boundaries of Quantum Genesis AI’s intellectual property ownership. By distinguishing its own research from that of Quantumzyme LLP, the Company aims to prevent confusion about the source and ownership of its core technologies. The announcement also highlights the Company’s commitment to transparency in corporate governance and its efforts to accurately represent its technological assets.
Quantum Genesis AI is focused on enzyme engineering, molecular modeling, and biocatalysis, leveraging artificial intelligence and computational modeling to drive innovation. The Company’s strategy includes using data-driven tools to support research and development across emerging sectors. For more information, visit qgaicorp.com and the Company’s profile at otcmarkets.com/stock/QGAI.
